Skip to main content

5 Result(s)

within F Magrangeas Remove this filter

and

  1. No Access

    Article

    Gene expression profile alone is inadequate in predicting complete response in multiple myeloma

    With advent of several treatment options in multiple myeloma (MM), a selection of effective regimen has become an important issue. Use of gene expression profile (GEP) is considered an important tool in predic...

    S B Amin, W-K Yip, S Minvielle, A Broyl, Y Li, B Hanlon, D Swanson, P K Shah… in Leukemia (2014)

  2. No Access

    Article

    Minor clone provides a reservoir for relapse in multiple myeloma

    Recent studies have provided direct evidence for genetic variegation in subclones for various cancer types. However, little is known about subclonal evolutionary processes according to treatment and subsequent...

    F Magrangeas, H Avet-Loiseau, W Gouraud, L Lodé, O Decaux, P Godmer, L Garderet… in Leukemia (2013)

  3. No Access

    Article

    CD33 is expressed on plasma cells of a significant number of myeloma patients, and may represent a therapeutic target

    N Robillard, S Wuillème, L Lodé, F Magrangeas, S Minvielle, H Avet-Loiseau in Leukemia (2005)

  4. No Access

    Article

    Ploidy, as detected by fluorescence in situ hybridization, defines different subgroups in multiple myeloma

    Ploidy appears as an important parameter in both the biology and the clinical evolution of multiple myeloma. However, its evaluation requires either a successful karyoty** (obtained in 30% of the patients) o...

    S Wuilleme, N Robillard, L Lodé, F Magrangeas, H Beris, J-L Harousseau… in Leukemia (2005)

  5. No Access

    Article

    Genetic heterogeneity in multiple myeloma

    In the past decade, many progresses have been made in our knowledge of the genetics of multiple myeloma. The use of molecular cytogenetic techniques has led to the identification of several recurrent (cyto)gen...

    F Magrangeas, L Lodé, S Wuilleme, S Minvielle, H Avet-Loiseau in Leukemia (2005)